Marco Prunotto MS, PhD

Prunotto is working in the Office of Innovation in the area of Immunology, Infectious Diseases and Ophthalmology in the Roche and Genentech late stage organization. We apply advanced analytics to large Ph3 and Ph4 datasets: to personalize treatments for each and every patient, to broaden the use of our drugs to novel disease indications and to relate back to discovery what we have learned from the use of our drugs in patients. Prior to that appointment, within Pharma, I've started as lab head, moved to a disease area leader position in the field of cardiovascular metabolism (renal & fibrosis). In that context I've matured a strong project and team leadership before moving on to new challenges within the discovery technologies Dept. as lead of the phenotypic drug discovery group.